Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Despite a decline in Q4 revenue and EBITDA, the company shows strong financial health with reduced debt and increased equity from an IPO. The company is in advanced talks with major global retailers, indicating potential growth. Management expects consistent margins and growth in key segments. Although geopolitical issues and commodity pricing present challenges, the company appears well-positioned to manage these. The positive outlook on future demand and improved financial metrics suggest a positive stock movement, especially given its small-cap status.
Consolidated Adjusted EBITDA Strong consolidated adjusted EBITDA consistent with outlook, driven by strong performance in Packaged Foods and Ingredients, specifically pasta and better-for-you products. Broad consumer trends, including value-seeking behavior and high-protein meal choices, contributed to growth.
Pasta Growth 20% growth rate for both revenue and adjusted EBITDA in 2025. 4-year CAGR for pasta, semolina, and bulgur business is 17% of revenue, showing gains in scale and distribution.
Packaged Foods and Ingredients Adjusted EBITDA Grew by 6% to $96 million, supported by strong pasta margins in Turkey and the U.S. better-for-you pasta manufacturing business. Excluding South Africa, the segment grew by 25% in 2025 or $14.5 million.
Packaged Foods and Ingredients Segment Revenue Excluding South Africa, grew by 3% from $630 million to $650 million. South Africa revenue was down 12%, but total segment revenue remained consistent year-over-year.
Turkish Pasta Revenues Reached $203 million, supported by recent capacity expansions completed in 2025 and new lines for gluten-free better-for-you pasta coming in 2026.
Value Added Processing Segment Revenue Full year segment revenue increased 2% to $1.7 billion, driven by Turkish and Australian shipments. Adjusted EBITDA in this segment grew from $45.9 million to $114.7 million over 4 years.
Q4 Revenue Declined to $446 million from $544 million due to lower commodity prices and reduced producer selling in Canada and the U.S.
Adjusted EBITDA (Q4) Decreased to $114.7 million from $128.5 million year-over-year due to Black Sea competition, tariff uncertainty, and product mix effects.
Food Security Sales $839 million in 2025, somewhat lower in Q4 due to timing of shipments. Long-term trend remains strong with robust demand expected in 2026 and beyond.
IPO Impact Equity increased to over $1.2 billion, debt reduced by $920 million. Adjusted net debt to adjusted EBITDA is now 0.3x compared to 3.35x at December 31, 2025. Approximately $55 million reduction in finance expense expected due to lower interest payments.
Pasta and Packaged Foods: Strong growth in pasta and better-for-you products, with a 20% growth rate in revenue and adjusted EBITDA in 2025. New gluten-free pasta lines in Turkey and the U.S. are expected to drive further growth.
Better-for-you Products: Significant growth in gluten-free and healthier pasta options, with Veggipasta achieving a top 30 position in the U.S. market and aiming for top 15 in 2026.
Emerging Markets Expansion: Focus on India with a new pasta facility under construction, aiming to strengthen global footprint and cost base.
Food Security Sales: Strong relationships with governments and aid agencies in regions like the Middle East, Lebanon, and Bangladesh, with $839 million in food security sales in 2025.
Operational Resilience: Despite geopolitical and economic challenges, the company adjusted to tariffs, port disruptions, and commodity price fluctuations, ending 2025 on strong footing.
Cost Reduction and Efficiency: Focus on cost containment and modular CapEx projects with 3-4 year paybacks to drive margin expansion.
IPO and Financial Flexibility: Successful IPO reduced debt by $920 million, improved adjusted net debt to EBITDA ratio to 0.3x, and increased equity to $1.2 billion.
Diversification: Shift from reliance on red lentils (60% in 2021 to 15% in 2025) to a broader product portfolio, enhancing resilience.
Tariffs and Economic Factors: Tariffs and other economic factors had an initial impact on the company's 2025 performance, though adjustments were made to mitigate these effects.
Port Disruptions and Shipping Challenges: The company faced disruptions in international shipping and port operations, which impacted operations in 2025.
Commodity Price Volatility: Lower commodity prices following the 2025 Canadian harvest impacted sales, though margins remained consistent.
Geopolitical Instability: The conflict in the Middle East and its impact on global shipping lanes posed challenges, requiring contingency plans for logistics and delivery.
Weather Events in South Africa: Unusual weather events, including excessive rain, negatively impacted the South Africa business segment in 2025.
Black Sea Competition and Tariff Uncertainty: Competition from the Black Sea region and tariff uncertainties affected adjusted EBITDA in 2025.
Hyperinflation Impacts: Hyperinflation impacts, while non-cash, were noted as a factor in financial reporting.
Revenue Expectations: The company expects commodity prices to continue to fall in 2026, leading to lower revenue but higher margins and less investment in working capital. Turkish pasta revenues reached $203 million in 2025, supported by capacity expansions, and new lines for gluten-free pasta are expected to come on stream in 2026, driving further growth.
Margin Projections: Margins in the Packaged Foods and Ingredients segment are expected to improve due to operating leverage in pasta manufacturing and growth in the higher-margin better-for-you business unit. The segment's margin profile is anticipated to increase to the 12%-13% range in the near term.
Capital Expenditures: The company plans to continue its modular CapEx strategy, which has shown 3- to 4-year paybacks, to support growth in pasta and better-for-you product lines. New capacity in India and additional lines in Minot are expected to drive future growth.
Market Trends: Global demand for healthier, protein-rich, and better-for-you products is driving growth. The company is capitalizing on these trends with its Veggipasta brand and private label store brands, which are expected to achieve double-digit growth in adjusted EBITDA in the near term.
Business Segment Performance: The Packaged Foods and Ingredients segment remains the fastest-growing part of the business, driven by strong global demand for pasta, pulses, and better-for-you products. The Value Added Processing segment is expected to see high single-digit growth in 2026 and beyond, supported by increased capacity utilization and margin improvements.
Geopolitical and Market Conditions: The company anticipates increased demand for food security sales in 2026 and 2027 due to geopolitical instability in the Middle East. AGT is positioned to meet this demand with its integrated supply chain and strong ties with government aid agencies.
Dividend Policy: The company plans to set a dividend policy in Q1 2026, reflecting confidence in the business and commitment to disciplined capital allocation.
Free Cash Flow Allocation: The company emphasized that free cash flow generation will enable funding for growth, dividend payments, and reduction of trade finance facilities.
Despite a decline in Q4 revenue and EBITDA, the company shows strong financial health with reduced debt and increased equity from an IPO. The company is in advanced talks with major global retailers, indicating potential growth. Management expects consistent margins and growth in key segments. Although geopolitical issues and commodity pricing present challenges, the company appears well-positioned to manage these. The positive outlook on future demand and improved financial metrics suggest a positive stock movement, especially given its small-cap status.
The earnings call summary indicates strong financial performance with reaffirmed revenue guidance, increased EPS guidance, and a focus on growth and profitability. The Q&A section reveals management's confidence in handling potential risks, such as competition and reimbursement changes. The company's strategic focus on expanding the patient pool and maintaining pricing stability, along with the positive outlook for reimbursement updates, supports a positive sentiment. However, some uncertainties remain, such as the impact of competition and physician fee cuts, but overall, the sentiment is positive, suggesting a stock price increase of 2% to 8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.